These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 38548529)

  • 1. Under-dosing and over-dosing of neuromuscular blocking drugs and reversal agents. Response to Br J Anaesth 2024; 132: 461-5.
    Michaelsen K; Jelacic S; Bowdle TA
    Br J Anaesth; 2024 Jun; 132(6):1330-1331. PubMed ID: 38548529
    [No Abstract]   [Full Text] [Related]  

  • 2. Under-dosing and over-dosing of neuromuscular blocking drugs and reversal agents: beware of the risks.
    Hunter JM; Blobner M
    Br J Anaesth; 2024 Mar; 132(3):461-465. PubMed ID: 38135525
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of neuromuscular blockade in ambulatory patients.
    Schreiber JU
    Curr Opin Anaesthesiol; 2014 Dec; 27(6):583-8. PubMed ID: 25251920
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Investigation of intraoperative dosing patterns of neuromuscular blocking agents.
    Palsen S; Wu A; Beutler SS; Gimlich R; Yang HK; Urman RD
    J Clin Monit Comput; 2019 Jun; 33(3):455-462. PubMed ID: 30094585
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuromuscular blockade in the elderly.
    Stankiewicz-Rudnicki M
    Anaesthesiol Intensive Ther; 2016; 48(4):257-260. PubMed ID: 27797097
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Use of neuromuscular blocking agents and reversal of blockade: guidelines from Sociedad Española de Anestesiología, Reanimación y Terapéutica del Dolor].
    Alvarez Gómez JA; Ariño Irujo JJ; Errando Oyonarte CL; Matínez Torrente F; Roigé i Solé J; Gilsanz Rodríguez F;
    Rev Esp Anestesiol Reanim; 2009 Dec; 56(10):616-27. PubMed ID: 20151524
    [No Abstract]   [Full Text] [Related]  

  • 7. [The priming technique in neuromuscular blockade --should we use it?].
    Kasperczyk G
    Anestezjol Intens Ter; 2008; 40(3):178-81. PubMed ID: 19469120
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is lower-dose sugammadex a cost-saving strategy for reversal of deep neuromuscular block? Facts and fiction.
    de Boer HD; Carlos RV; Brull SJ
    BMC Anesthesiol; 2018 Nov; 18(1):159. PubMed ID: 30400850
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preparing for the unexpected: special considerations and complications after sugammadex administration.
    Iwasaki H; Renew JR; Kunisawa T; Brull SJ
    BMC Anesthesiol; 2017 Oct; 17(1):140. PubMed ID: 29041919
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Actual versus ideal body weight dosing of sugammadex in morbidly obese patients offers faster reversal of rocuronium- or vecuronium-induced deep or moderate neuromuscular block: a randomized clinical trial.
    Horrow JC; Li W; Blobner M; Lombard J; Speek M; DeAngelis M; Herring WJ
    BMC Anesthesiol; 2021 Feb; 21(1):62. PubMed ID: 33639839
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Personalized neuromuscular blockade through control: clinical and technical evaluation.
    Silva MM; Mendonca T; Esteves S
    Annu Int Conf IEEE Eng Med Biol Soc; 2008; 2008():5826-9. PubMed ID: 19164042
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Survey of postoperative residual curarization, acute respiratory events and approach of anesthesiologists.
    Aytac I; Postaci A; Aytac B; Sacan O; Alay GH; Celik B; Kahveci K; Dikmen B
    Braz J Anesthesiol; 2016; 66(1):55-62. PubMed ID: 26768931
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative Neuromuscular Monitoring and Postoperative Outcomes: A Narrative Review.
    Murphy GS; Brull SJ
    Anesthesiology; 2022 Feb; 136(2):345-361. PubMed ID: 34813652
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of Pharmacologic Paralysis in Acute Respiratory Distress Syndrome.
    Syed A; Kobzik A; Huang DT
    Semin Respir Crit Care Med; 2019 Feb; 40(1):101-113. PubMed ID: 31060092
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reducing the dose of neuromuscular blocking agents with adjuncts: a systematic review and meta-analysis.
    Weber V; Abbott TEF; Ackland GL
    Br J Anaesth; 2021 Mar; 126(3):608-621. PubMed ID: 33218672
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Myorelaxation tactic with sugammadex in surgery with neurophysiological monitoring].
    Anesteziol Reanimatol; 2012; (4):80-1. PubMed ID: 23082654
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Onset of neuromuscular blockade: more than just the time to get there.
    Donati F
    Anesth Analg; 2013 Oct; 117(4):757-759. PubMed ID: 24057949
    [No Abstract]   [Full Text] [Related]  

  • 18. Reversal of neuromuscular block with neostigmine versus sugammadex: comment on Br J Anaesth 2021; 127: 316-23.
    Powell L; Kidd L
    Br J Anaesth; 2022 Jul; 129(1):e8-e10. PubMed ID: 35469673
    [No Abstract]   [Full Text] [Related]  

  • 19. Acyclic cucurbit[n]uril-type molecular containers bind neuromuscular blocking agents in vitro and reverse neuromuscular block in vivo.
    Ma D; Zhang B; Hoffmann U; Sundrup MG; Eikermann M; Isaacs L
    Angew Chem Int Ed Engl; 2012 Nov; 51(45):11358-62. PubMed ID: 23047893
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Compared efficacy and tolerance of the neuromuscular blockade induced by brand-name (Nimbex®) and generic (Cisatrex®) of cisatracurium in mechanically ventilated critically ill patients: a crossover double-blind randomized study.
    Fraj N; Meddeb K; Azouzi A; Romdhani S; Saad HB; Boussarsar M
    Pan Afr Med J; 2020; 37():346. PubMed ID: 33738034
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.